| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2012PLoSO...743874H |
| P356 | DOI | 10.1371/JOURNAL.PONE.0043874 |
| P932 | PMC publication ID | 3427312 |
| P698 | PubMed publication ID | 22937115 |
| P5875 | ResearchGate publication ID | 230769846 |
| P2093 | author name string | Tian Lan | |
| Xiaoyan Shen | |||
| Juan Huang | |||
| Peiqing Liu | |||
| Jing Peng | |||
| Heqing Huang | |||
| Weihua Liu | |||
| Kaipeng Huang | |||
| Shaogui Wang | |||
| Xi Xie | |||
| P2860 | cites work | The S1P(2) receptor expressed in human platelets is linked to the RhoA-Rho kinase pathway and is down regulated in type 2 diabetes. | Q53424335 |
| Sphingosine-1 phosphate prevents monocyte/endothelial interactions in type 1 diabetic NOD mice through activation of the S1P1 receptor | Q28262554 | ||
| Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: involvement of NF-κB signaling pathway | Q28573256 | ||
| Sphingosine-1-phosphate: an enigmatic signalling lipid | Q29620563 | ||
| Platelet-released phospholipids link haemostasis and angiogenesis | Q31882372 | ||
| Sphingosine-1-phosphate receptor-2 deficiency leads to inhibition of macrophage proinflammatory activities and atherosclerosis in apoE-deficient mice | Q34245331 | ||
| An update on sphingosine-1-phosphate and other sphingolipid mediators | Q34402916 | ||
| Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins | Q34552498 | ||
| Berberine inhibits aldose reductase and oxidative stress in rat mesangial cells cultured under high glucose | Q34777983 | ||
| Sphingosine kinase-1 pathway mediates high glucose-induced fibronectin expression in glomerular mesangial cells | Q35595685 | ||
| Biologically active sphingolipids in cancer pathogenesis and treatment | Q35852313 | ||
| Pathogenetic mechanisms of diabetic nephropathy | Q36153062 | ||
| Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular diseases | Q36393610 | ||
| Diabetic nephropathy: from mechanisms to rational therapies. | Q36541571 | ||
| Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate | Q36797828 | ||
| Autocrine and paracrine roles of sphingosine-1-phosphate | Q36955411 | ||
| A glimpse of various pathogenetic mechanisms of diabetic nephropathy | Q36979205 | ||
| Dissecting the role of the S1P/S1PR axis in health and disease. | Q37830235 | ||
| Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. | Q37871339 | ||
| TNFalpha-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, Akt and NFkappaB signaling | Q39634008 | ||
| Transcriptional regulation of connective tissue growth factor by sphingosine 1-phosphate in rat cultured mesangial cells | Q40429151 | ||
| Connective tissue growth factor (CTGF) promotes activated mesangial cell survival via up-regulation of mitogen-activated protein kinase phosphatase-1 (MKP-1). | Q41824997 | ||
| S1P2 receptor mediates sphingosine-1-phosphate-induced fibronectin expression via MAPK signaling pathway in mesangial cells under high glucose condition | Q42720652 | ||
| Berberine ameliorates renal injury in diabetic C57BL/6 mice: Involvement of suppression of SphK-S1P signaling pathway | Q42963879 | ||
| Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury | Q43071829 | ||
| Sphingosine 1-phosphate stimulates rat mesangial cell proliferation from outside the cells | Q43935598 | ||
| Sphingosine kinase type 1 induces G12/13-mediated stress fiber formation, yet promotes growth and survival independent of G protein-coupled receptors | Q44578313 | ||
| Unbalanced expression of sphingosine 1-phosphate receptors in diabetic nephropathy. | Q46100345 | ||
| Carnosine inhibits high glucose-induced mesangial cell proliferation through mediating cell cycle progression | Q46156477 | ||
| Berberine reduces fibronectin and collagen accumulation in rat glomerular mesangial cells cultured under high glucose condition | Q46163975 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | diabetic nephropathy | Q1129105 |
| P304 | page(s) | e43874 | |
| P577 | publication date | 2012-08-24 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Berberine reduces fibronectin expression by suppressing the S1P-S1P2 receptor pathway in experimental diabetic nephropathy models | |
| P478 | volume | 7 |
| Q50089534 | Berberine Ameliorates Diabetic Neuropathy: TRPV1 Modulation by PKC Pathway |
| Q51243597 | Berberine Preconditioning Protects Neurons Against Ischemia via Sphingosine-1-Phosphate and Hypoxia-Inducible Factor-1[Formula: see text]. |
| Q39208146 | Berberine ameliorates renal interstitial fibrosis induced by unilateral ureteral obstruction in rats |
| Q52586128 | Cell Adhesion Molecules are Mediated by Photobiomodulation at 660 nm in Diabetic Wounded Fibroblast Cells. |
| Q49858961 | Chinese medicine for diabetic kidney disease in China |
| Q36119717 | Differential Effects of Long Term FTY720 Treatment on Endothelial versus Smooth Muscle Cell Signaling to S1P in Rat Mesenteric Arteries |
| Q34081401 | Effects of high glucose on integrin activity and fibronectin matrix assembly by mesangial cells |
| Q28115790 | Galectin-1 stimulates motility of human umbilical cord blood-derived mesenchymal stem cells by downregulation of smad2/3-dependent collagen 3/5 and upregulation of NF-κB-dependent fibronectin/laminin 5 expression |
| Q92619096 | Hawthorne leaf flavonoids prevent oxidative stress injury of renal tissues in rats with diabetic kidney disease by regulating the p38 MAPK signaling pathway |
| Q90219783 | Lipid mediators of insulin signaling in diabetic kidney disease |
| Q92853737 | Lysophosphatidic Acid Signaling in Diabetic Nephropathy |
| Q40704553 | Melatonin inhibits the sphingosine kinase 1/sphingosine-1-phosphate signaling pathway in rabbits with fulminant hepatitis of viral origin. |
| Q38879580 | Mitogen-activated protein kinase mediates mevalonate-stimulated human mesangial cell proliferation |
| Q37210162 | Protective Effects of Berberine on Renal Injury in Streptozotocin (STZ)-Induced Diabetic Mice |
| Q89582740 | Renoprotective effects of Gushen Jiedu capsule on diabetic nephropathy in rats |
| Q38217707 | Research progress in signalling pathway in diabetic nephropathy |
| Q92510491 | Rhizoma coptidis as a Potential Treatment Agent for Type 2 Diabetes Mellitus and the Underlying Mechanisms: A Review |
| Q37675523 | Sphingosine-1-phosphate acts as a key molecule in the direct mediation of renal fibrosis. |
| Q53070283 | Sphingosine-1-phosphate induces differentiation of cultured renal tubular epithelial cells under Rho kinase activation via the S1P2 receptor. |
| Q47945057 | The role and mechanism of glutamic NMDA receptor in the mechanical hyperalgesia in diabetic rats. |
| Q94950021 | Therapeutic Application of Nutraceuticals in Diabetic Nephropathy: Current Evidence and Future Implications |
| Q34256862 | Withania coagulans fruit extract reduces oxidative stress and inflammation in kidneys of streptozotocin-induced diabetic rats |
Search more.